Biofrontera Inc.
BFRI
$0.86
$0.0121.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.20M | -1.40M | -5.67M | -257.00K | -10.44M |
| Total Depreciation and Amortization | 219.00K | 221.00K | 312.00K | 309.00K | 307.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -236.00K | 50.00K | 1.01M | -5.11M | 4.19M |
| Change in Net Operating Assets | 103.00K | 108.00K | 3.14M | 342.00K | 2.62M |
| Cash from Operations | -4.12M | -1.02M | -1.21M | -4.72M | -3.33M |
| Capital Expenditure | -3.00K | -1.00K | 0.00 | 48.00K | -57.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | -50.00K | 57.00K |
| Cash from Investing | -3.00K | -1.00K | 0.00 | -2.00K | 0.00 |
| Total Debt Issued | -- | 4.05M | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -298.00K | -2.15M | -1.86M |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 7.44M | 7.66M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 4.05M | -298.00K | 5.28M | 5.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.12M | 3.03M | -1.51M | 562.00K | 2.47M |